Updated - February 09, 2026 at 09:42 PM.
This refers to ‘Trade reset’ (February 9) which proposes a reduction in US tariffs on Indian goods from about 50 per cent to 18 per cent. This is a welcome development as it enhances the competitiveness of Indian exports to the US.
However, it is essential that all ambiguities, especially those relating to market access, sectoral commitments, and non-tariff barriers are clearly resolved before formal signing.
Regarding Russian oil imports, India should unequivocally reiterate its long-standing policy of sourcing energy at the most competitive prices from its trading partners, including the US, while remaining compliant with existing sanctions norms. Any comprehensive trade agreement must ensure a level-playing field, keeping in mind the core interests of both countries, with particular sensitivity towards sectors such as agriculture, dairy, restrictions on GM agricultural products, and fuel security.
Srinivasan Velamur
Chennai
The import of $500 billion worth of American energy products, aircraft and aircraft parts mentioned in the India-US deal is baffling because it means $100 billion a year while our yearly imports are only around $50 billion at present.
The government should clarify whether this is aspirational or a concrete plan or a binding agreement. Energy security should be driven only by price and reliability.
Bal Govind
Noida
It is with reference to the article ‘Institutional reforms vital to become Viksit Bharat’(February 9).
Viksit Bharat is a transformative initiative aiming to holistic development across sectors, fostering inclusivity, reducing disparities and empowering youth to build a modern developed nation by 2047. A collaborative approach involving the government, private sector and active citizen participation is also essential.
Change in labour laws, privatisation moves, creation of land banks for industry, transforming or creating new legal frameworks through Constitutional amendments are vital to make the economy prosperous economy by 2047.
P Victor Selvaraj
Palayamkottai (TN)
The article ‘Custom waiver alone cannot make medicines affordable’ (February 9 ) hit the nail on the head. The government should take effective steps to ensure that cancer medicines are not only available to patients, but also at affordable prices.
After all, it’s medicines that delay the inevitable death of cancer patients.
S Ramakrishnasayee
Chennai
Published on February 9, 2026
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。